Literature DB >> 24265483

Hospitalizations for acute lower respiratory tract infection due to respiratory syncytial virus in Thailand, 2008-2011.

Sathapana Naorat1, Malinee Chittaganpitch, Somsak Thamthitiwat, Sununta Henchaichon, Pongpun Sawatwong, Prasong Srisaengchai, Ying Lu, Somchai Chuananon, Tussanee Amornintapichet, Somrak Chantra, Dean D Erdman, Susan A Maloney, Passakorn Akarasewi, Henry C Baggett.   

Abstract

BACKGROUND: Few population-based estimates of the incidence of respiratory syncytial virus (RSV) infection in low- or middle-income countries are available. We describe the incidence and epidemiology of hospitalizations for RSV-associated acute lower respiratory tract infection (ALRI) detected by active population-based surveillance in 2 rural Thailand provinces during 2008-2011.
METHODS: Patients hospitalized with ALRI were systematically sampled. Consenting patients provided nasopharyngeal swab specimens for RSV testing by real-time reverse-transcription polymerase chain reaction.
RESULTS: Of 13 982 enrolled patients hospitalized with ALRI, 1137 (8.1%) were RSV positive. After adjustment for sampling and nonenrollment, the incidence of RSV-associated ALRI hospitalization was 85 cases per 100,000 persons/year. The highest rates occurred among children aged <5 years (981 cases per 100,000 persons/year) and <1 year (1543 cases per 100,000 persons/year). Rates were low among older children and young adults but high among persons aged >65 years (130 cases per 100,000 persons/year). Eight (0.7%) RSV-infected study patients died during hospitalization. Annual RSV hospitalizations peaked during July-October with almost no documented RSV hospitalizations during January-June.
CONCLUSIONS: Our findings demonstrate the substantial contribution of RSV to global ALRI burden, especially in children aged <5 years and the elderly, and underscore the urgent need for effective prevention measures.

Entities:  

Keywords:  Thailand; acute lower respiratory infection; respiratory syncytial virus

Mesh:

Year:  2013        PMID: 24265483     DOI: 10.1093/infdis/jit456

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  RSV associated hospitalizations in children in Karachi, Pakistan: Implications for vaccine prevention strategies.

Authors:  Asad Ali; Mohammad Tahir Yousafzai; Rabbia Waris; Fatima Jafri; Fatima Aziz; Imran Naeem Abbasi; Anita Zaidi
Journal:  J Med Virol       Date:  2017-02-24       Impact factor: 2.327

2.  Respiratory syncytial virus hospitalization in middle-aged and older adults.

Authors:  Ryan E Malosh; Emily T Martin; Amy P Callear; Joshua G Petrie; Adam S Lauring; Lois Lamerato; Alicia M Fry; Jill Ferdinands; Brendan Flannery; Arnold S Monto
Journal:  J Clin Virol       Date:  2017-09-07       Impact factor: 3.168

3.  Respiratory syncytial virus infection in older adults: an under-recognized problem.

Authors:  Angela R Branche; Ann R Falsey
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

4.  Respiratory syncytial virus among children hospitalized with severe acute respiratory infection in Kashmir, a temperate region in northern India.

Authors:  Parvaiz A Koul; Siddhartha Saha; Kaisar A Kaul; Hyder Mir; Varsha Potdar; Mandeep Chadha; Danielle Iuliano; Kathryn E Lafond; Renu B Lal; Anand Krishnan
Journal:  J Glob Health       Date:  2022-07-16       Impact factor: 7.664

5.  Molecular epidemiological surveillance of viral agents of acute lower respiratory tract infections in children in Accra, Ghana.

Authors:  Anna Aba Kafintu-Kwashie; Nicholas Israel Nii-Trebi; Evangeline Obodai; Margaret Neizer; Theophilus Korku Adiku; John Kofi Odoom
Journal:  BMC Pediatr       Date:  2022-06-24       Impact factor: 2.567

6.  Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting.

Authors:  Jocelyn Moyes; Sibongile Walaza; Marthi Pretorius; Michelle Groome; Anne von Gottberg; Nicole Wolter; Sumayya Haffejee; Ebrahim Variava; Adam L Cohen; Stefano Tempia; Kathleen Kahn; Halima Dawood; Marietjie Venter; Cheryl Cohen; Shabir A Madhi
Journal:  J Infect       Date:  2017-07-01       Impact factor: 6.072

7.  Hospitalizations associated with influenza and respiratory syncytial virus among patients attending a network of private hospitals in South Africa, 2007-2012.

Authors:  Robert Kyeyagalire; Stefano Tempia; Adam L Cohen; Adrian D Smith; Johanna M McAnerney; Veerle Dermaux-Msimang; Cheryl Cohen
Journal:  BMC Infect Dis       Date:  2014-12-16       Impact factor: 3.090

8.  Deaths associated with respiratory syncytial and influenza viruses among persons ≥5 years of age in HIV-prevalent area, South Africa, 1998-2009(1).

Authors:  Stefano Tempia; Sibongile Walaza; Cecile Viboud; Adam L Cohen; Shabir A Madhi; Marietjie Venter; Claire von Mollendorf; Jocelyn Moyes; Johanna M McAnerney; Cheryl Cohen
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

9.  Clinical Presentation and Birth Outcomes Associated with Respiratory Syncytial Virus Infection in Pregnancy.

Authors:  Helen Y Chu; Joanne Katz; James Tielsch; Subarna K Khatry; Laxman Shrestha; Steven C LeClerq; Amalia Magaret; Jane Kuypers; Mark C Steinhoff; Janet A Englund
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

10.  Emergence of BA9 genotype of human respiratory syncytial virus subgroup B in China from 2006 to 2014.

Authors:  Jinhua Song; Huiling Wang; Jing Shi; Aili Cui; Yanzhi Huang; Liwei Sun; Xingyu Xiang; Chaofeng Ma; Pengbo Yu; Zifeng Yang; Qi Li; Teresa I Ng; Yan Zhang; Rongbo Zhang; Wenbo Xu
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.